Ranbaxy Pharmaceutical to close with loss of 100 jobs
05 April 2016
Ranbaxy Pharmaceutical is to close its plant in Cashel, Co Tipperary, with the loss of 100 jobs. The plant which has been in business for over 30 years on the Cork Road, make and package generic drugs.
The facility is owned by Sun Pharma, which is the fifth largest drugs producer in the world. Sun Pharma took over Ranbaxy’s international operations last year.
Negotiations over the future of the facility had been taking place for a number of months, with Sun Pharma looking to sell the plant. It had stated that it intended to scale down or divest itself of certain operations worldwide, with the Cashel site said to be one of the locations to be either sold or divested.
In a statement the company said it decided to cease operations at its Cashel unit as part of an ongoing operations network review. It added it expects “to cease operations at Cashel by end of current calendar year”.
The company said it would move certain roles to other facilities within its global operations network. It will engage with trade unions and employee representatives in the coming months and “at the end of this period, if necessary, the company may proceed with redundancies”.
Tipperary Chamber expressed its disappointment with the decision to close the plant, saying it has been a “consistent employer in the local economy for many years”.http://www.engineersjournal.ie/2016/04/05/ranbaxy-pharmaceutical-to-close-with-loss-of-100-jobs/http://www.engineersjournal.ie/wp-content/uploads/2016/03/aaanews.pnghttp://www.engineersjournal.ie/wp-content/uploads/2016/03/aaanews-300x252.pngNewsbiomedical,jobs,pharma,Tipperary